This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
Newsramp
newsramp.com
did:plc:xlsujlrwr5xpfxgaf4pixhri
Regentis Biomaterials (RGNT) is advancing GelrinC, a 10-minute off-the-shelf knee cartilage implant targeting 472,500 U.S. procedures annually with no current regenerative option. FDA trial is 50%+ enrolled. #RegenerativeMedicine #Orthopedics
2026-05-29T21:37:15.678Z